Skip to main navigation Skip to search Skip to main content

Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.

  • Martin Schaefer
  • , Rahul Sarkar
  • , Viola Knop
  • , Susanne Effenberger
  • , Astrid Friebe
  • , Loni Heinze
  • , Ulrich Spengler
  • , Thomas Schlaepfer
  • , Jens Reimer
  • , Peter Buggisch
  • , Johann Ockenga
  • , Ralph Link
  • , Michael Rentrop
  • , Hans Weidenbach
  • , Gwendolyn Fromm
  • , Klaus Lieb
  • , Thomas F Baumert
  • , Andreas Heinz
  • , Thomas Discher
  • , Konrad Neumann
  • Stefan Zeuzem, Thomas Berg

Research output: Contribution to journal › Original Article › peer-review

57 Citations (Web of Science)
Original languageEnglish
Pages (from-to)94-103
JournalANNALS OF INTERNAL MEDICINE
Volume157
Issue number2
DOIs
Publication statusPublished - 2012

Keywords

  • INTERFERON-INDUCED DEPRESSION
  • PLACEBO-CONTROLLED TRIAL
  • GENOTYPE 1 INFECTION
  • DOUBLE-BLIND
  • MAJOR DEPRESSION
  • HCV INFECTION
  • ALPHA THERAPY
  • DSM-IV
  • RIBAVIRIN
  • RISK

Cite this